Stay updated on Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. No substantive changes to study content or page behavior were observed.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page now displays a minor version update from Revision: v3.4.0 to v3.4.1, with no visible changes to core content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check34 days agoChange DetectedA new 'Last Update Posted' label appears in the Study Record Dates section, and 'Last Update Posted (Estimated)' is removed.SummaryDifference0.0%

- Check41 days agoChange DetectedThe changes show a minor revision update from v3.3.3 to v3.3.4; no substantive study details appear affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedLocations section updated to add Lower Saxony as a trial site, expanding available locations. The page also removes the Lower Saxony Locations entry and the HHS Vulnerability Disclosure reference from the footer area.SummaryDifference0.2%

- Check91 days agoChange DetectedThe page revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial page.